Yunhong Huang

Yunhong Huang's work experience includes positions as a Principal Scientist at APRINOIA Therapeutics starting in 2023, a Research Instructor at the University of Pittsburgh from 2019 to 2023, a Postdoctoral Research Associate at the University of Pittsburgh from 2016 to 2018, and a Scientist at GlaxoSmithKline from 2008 to 2012.

Yunhong Huang obtained a Master's Degree in Biomedical Sciences from the University of Glasgow in 2004-2005. Later, from 2012 to 2016, they pursued a Doctor of Philosophy (Ph.D.) degree in Biomedical Sciences with a focus on Neuroscience at KU Leuven.